Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress

Diabetes

Volumn 55, Issue 10, 2006, Pages 2863-2870

  Duarte, Ana I ^a   Proença, Teresa ^a   Oliveira, Catarina R ^b   Santos, Maria S ^a   Rego, A Cristina ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE DERIVATIVE; ADENOSINE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; ECTO 5' NUCLEOTIDASE; GLUCOSE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PYRUVIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 4-NITROBENZYLTHIOINOSINE; ADENINE NUCLEOTIDE; ANDROSTANE DERIVATIVE; CHROMONE DERIVATIVE; DRUG DERIVATIVE; FLAVONOID; LACTIC ACID; MERCAPTOPURINE RIBOSIDE; MORPHOLINE DERIVATIVE; NITROBENZYLTHIOINOSINE; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CATABOLISM; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; EMBRYO; ENERGY METABOLISM; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYDROLYSIS; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; BRAIN CORTEX; CELL CULTURE; CYTOLOGY; DRUG EFFECT; METABOLISM; NERVE CELL; PRENATAL DEVELOPMENT; WISTAR RAT;

ADENINE NUCLEOTIDES; ADENOSINE; ANDROSTADIENES; ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; CHROMONES; FLAVONOIDS; GLUCOSE; INSULIN; LACTIC ACID; MORPHOLINES; NEURONS; OXIDATIVE STRESS; PHOSPHOCREATINE; PYRUVIC ACID; RATS; RATS, WISTAR; THIOINOSINE;

EID: 33750882488     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0030     Document Type: Article

References (50)

1. Gerozissis K: Brain insulin and feeding: a bi-directional communication. Eur J Pharmacol 490:59-70, 2004
2. Sankar R, Thamotharan S, Shin D, Moley KH, Devaskar SU: Insulin-responsive glucose transporters-GLUT8 and GLUT4 are expressed in the developing mammalian brain. Brain Res Mol Brain Res 107:157-165, 2002
3. Hoyer S: Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490:115-125, 2004
4. Schechter R, Beju D, Gaffney T, Schaefer F, Whetsell L: Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system. Brain Res 736:16-27, 1996
5. Gerozissis K: Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 23:1-25, 2003
6. Pellerin L, Magistretti PJ: Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 91:10625-10629, 1994
7. Vannucci SJ, Maher F, Simpson IA: Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21:2-21, 1997
8. Choeiri C, Staines W, Messier C: Immunohistochemical localization and quantification of glucose transporters in the mouse brain. Neuroscience 111:19-34, 2002
9. Stockhorst U, de Fries D, Steingrueber HJ, Scherbaumb WA: Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans. Physiol Behav 83:47-54, 2004
10. Kokoszka JE, Coskun P, Esposito LA, Wallace DC: Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci U S A 98:2278-2283, 2001
11. Chong ZZ, Li F, Maiese K: Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75:207-246, 2005
12. Butterfield AD, Castegna A, Lauderback CM, Drake J: Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23:655-664, 2002
13. Rabini RA, Tesei M, Galeazzi T, Dousset N, Ferretti G, Mazzanti L: Increased susceptibility to peroxidation of VLDL from non-insulin-dependent diabetic patients: a possible correlation with fatty acid composition. Mol Cell Biochem 199:63-67, 1999
14. Makar TK, Hungund BL, Cook GA, Kashfi K, Cooper AJ: Lipid metabolism and membrane composition are altered in the brains of type II diabetic mice. J Neurochem 64:2159-2168, 1995
15. de Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE: Fatal strokes in hyperglycemic cats. Stroke 20:1707-1715, 1989
16. Yip PK, He YY, Hsu CY, Garg N, Marangos P, Hogan EL: Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology 41:899-905, 1991
17. Voll CL, Auer RN: The effect of postischemic blood glucose levels on ischemic brain damage in the rat. Ann Neurol 24:638-646, 1988
18. Garg R, Chaudhuri A, Munschauer F, Dandona P: Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 37:267-273, 2006
19. Duarte AI, Santos MS, Oliveira CR, Rego AC: Insulin neuroprotection against oxidative stress in cortical neurons: involvement of uric acid and glutathione antioxidant defenses. Free Radic Biol Med 39:876-889, 2005
20. Almeida S, Domingues A, Rodrigues L, Oliveira CR, Rego AC: FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitro-propionic acid in rat primary cortical cultures. Neurobiol Dis 17:435-444, 2004
21. Rego AC, Santos MS, Oliveira CR: Adenosine triphosphate degradation products after oxidative stress and metabolic dysfunction in cultured retinal cells. J Neurochem 69:1228-1235, 1997
22. Sedmak JJ, Grossberg FE: A rapid, sensitive and versatile assay for protein using coomassie brilliant blue G250. Anal Biochem 79:544-552, 1977
23. Heinz F, Weißer H: Creatine phosphate. In Methods of Enzymatic Analysis. 3rd ed. Bergmeyer HU, Bergmeyer J, Graβl M, Eds. VCH, 1985, p. 507-514
24. Erecinska M, Nelson D: Effects of 3-nitropropionic acid on synaptosomal energy and transmitter metabolism: relevance to neurodegenerative brain diseases. J Neurochem 63:1033-1041, 1994
25. Gupta RC, Dettbarn WD: Prevention of kainic acid seizures-induced changes in levels of nitric oxide and high-energy phosphates by 7-nitroindazole in rat brain regions. Brain Res 981:184-192, 2003
26. Schulte G, Fredholm BB: Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15:813-827, 2003
27. Cunha RA: Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 38:107-125, 2001
28. 3H]aspartate release in cultured retina cells exposed to oxidative stress. Neurochem Int 36:255-265, 2000
29. Cunha RA, Sebastião AM, Ribeiro JA: Ecto-5′-nucleotidase is associated with cholinergic nerve terminals in the hippocampus but not in the cerebral cortex of the rat. J Neurochem 59:657-666, 1992
30. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP: Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 17:1046-1054, 1997
31. Lovell MA, Xie C, Markesbery WR: Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Rad Biol Med 29:714-720, 2000
32. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, Evans JL: Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes 50:404-410, 2001
33. Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, Beal MF: Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci 18:156-163, 1998
34. Mishra OP, Delivoria-Papadopoulos M, Cahillane G, Wagerle LC: Lipid peroxidation as the mechanism of modification of brain 5′-nucleotidase activity in vitro. Neurochem Res 15:237-242, 1990
35. Almeida CG, Mendonca A, Cunha RA, Ribeiro JA: Adenosine promotes neuronal recovery from reactive oxygen species induced lesion in rat hippocampal slices. Neurosci Lett 339:127-130, 2003
36. 1 adenosine receptor ligands in rat brain membranes. J Neurochem Int 26:263-268, 1995
37. 2 receptors in the striatum of young adult and aged rats. Neurochem Int 45:733-738, 2004
38. Seaquist ER, Damberg GS, Tkac I, Gruetter R: The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 50:2203-2209, 2001
39. Prasannan KG: Effect of insulin on glucose metabolism in cerebral cortex slices under aerobic and anaerobic conditions. J Neurochem 19:1825-1828, 1972
40. 18fluorodeoxyglucose positron emission tomography study. Diabetes 51:3384-3390, 2002
41. Watson GS, Craft S: Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. Eur J Pharmacol 490:97-113, 2004
42. Mattson MP, Maudsley S, Martin B: A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Res Rev 3:445-464, 2004
43. Hamabe W, Fujita R, Ueda H: Neuronal necrosis inhibition by insulin through protein kinase C activation. J Pharmacol Exp Ther 307:205-212, 2003
44. Whitesell RR, Ward M, McCall AL, Granner DK, May JM: Coupled glucose transport and metabolism in cultured neuronal cells: determination of the rate-limiting step. J Cereb Blood Flow Metab 15:814-826, 1995
45. Huang TJ, Verkhratsky A, Fernyhough P: Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-K in adult sensory neurons. Mol Cell Neurosci 28:42-54, 2005
46. Henneberg N, Hoyer S: Short-term or long-term intracerebroventricular (ivc) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat. Neurosci Lett 175:153-156, 1994
47. van der Heide LP, Kamal A, Artola A, Gispen WH, Ramakers GMJ: Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-D-aspartate receptor and phosphatidyl-inositol-3-K-dependent manner. J Neurochem 94:1158-1166, 2005
48. Voll CL, Auer RN: Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. J Cereb Blood Flow Metab 11:1006-1014, 1991
49. Hamilton MG, Tranmer BI, Auer RN: Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 82:262-268, 1995
50. Johan Groeneveld AB, Beishuizen A, Visser FC: Insulin: a wonder drug in the critically ill? Crit Care 6:102-105, 2002